Consensus on Application of Third-generation EGFR-TKI in EGFR Mutated NSCLC
(2022 Version).
10.3779/j.issn.1009-3419.2022.101.47
- Collective Name:Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee;Anti-cancer Drug Safety Management Committee (ASMC)
- Publication Type:Journal Article
- Keywords:
Consensus;
ErbB receptors;
Lung neoplasms;
Receptor protein-tyrosine kinases
- MeSH:
Carcinoma, Non-Small-Cell Lung/genetics*;
Consensus;
ErbB Receptors/genetics*;
Humans;
Lung Neoplasms/genetics*;
Mutation;
Protein Kinase Inhibitors/therapeutic use*
- From:
Chinese Journal of Lung Cancer
2022;25(9):627-641
- CountryChina
- Language:Chinese
